Cargando…

A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs)

Detalles Bibliográficos
Autor principal: Hepburne-Scott, Henry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991266/
http://dx.doi.org/10.1186/2051-1426-1-S1-P103
_version_ 1782312404619624448
author Hepburne-Scott, Henry
author_facet Hepburne-Scott, Henry
author_sort Hepburne-Scott, Henry
collection PubMed
description
format Online
Article
Text
id pubmed-3991266
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39912662014-05-05 A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs) Hepburne-Scott, Henry J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991266/ http://dx.doi.org/10.1186/2051-1426-1-S1-P103 Text en Copyright © 2013 Hepburne-Scott; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Hepburne-Scott, Henry
A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs)
title A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs)
title_full A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs)
title_fullStr A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs)
title_full_unstemmed A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs)
title_short A novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (MDSCs)
title_sort novel biomarker assay for cancer immunotherapy development based on myeloid derived supressor cells (mdscs)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991266/
http://dx.doi.org/10.1186/2051-1426-1-S1-P103
work_keys_str_mv AT hepburnescotthenry anovelbiomarkerassayforcancerimmunotherapydevelopmentbasedonmyeloidderivedsupressorcellsmdscs
AT hepburnescotthenry novelbiomarkerassayforcancerimmunotherapydevelopmentbasedonmyeloidderivedsupressorcellsmdscs